Anti-Angiogenic Drugs in the Treatment of Metastatic Renal Cell Carcinoma: Advances in Clinical Application

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|13|3|381-391

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.13, Iss.3, 2015-05, pp. : 381-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-angiogenic Drugs as an Adjunctive Therapy in the Surgical Treatment of Diabetic Retinopathy

By  

Current Diabetes Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 52-56

Bentham Science Publishers

Access to resources Recommend Favorite

Thromboembolic Events in Patients Treated with Anti-Angiogenic Drugs

By  

Current Vascular Pharmacology, Vol. 8, Iss. 1, 2010-01 ,pp. : 102-113

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic therapy: Rationale, challenges and clinical studies

By Longo R.   Sarmiento R.   Fanelli M.   Capaccetti B.   Gattuso D.   Gasparini G.  

Angiogenesis, Vol. 5, Iss. 4, 2002-01 ,pp. : 237-256

Springer Publishing Company

Access to resources Recommend Favorite

Octreotide scanning in the detection of metastatic renal cell carcinoma

By McCloskey Marguerite C.   Smyth John   Marshall Wendy   Leonard Niall  

NDT PLUS, Vol. 1, Iss. 5, 2008-10 ,pp. : 369-370

Oxford University Press

Access to resources Recommend Favorite

Duodenal Bleeding from Metastatic Renal Cell Carcinoma

By  

Case Reports in Gastroenterology, Vol. 5, Iss. 1, 2011-04 ,pp. : 249-257

Karger

Access to resources Recommend Favorite